Patents Assigned to PERFECT (CHINA) CO., LTD.
  • Patent number: 11607435
    Abstract: This invention relates to novel probiotic Bifidobacteria strains, particularly, B. pseudocatenulatum strains, and their use as probiotic, and food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of obesity, diabetes, and related conditions.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: March 21, 2023
    Assignee: PERFECT (CHINA) CO., LTD.
    Inventors: Liping Zhao, Guojun Wu, Menghui Zhang, Chenhong Zhang, Huan Wu
  • Patent number: 11373730
    Abstract: A method in which a microorganism operational taxonomic unit (OTU) in a sample is defined based on a DNA sequence of a system generation information gene of microorganism in the sample. In the method, qualified sequence segments are obtained by means of processing and reading of an original sequence; the segments are sorted according to a relative abundance value of each segment; and only the qualified sequences with the high abundance values are used to obtain the temporary OTU. The qualified sequences with the low abundance values are reallocated; and the qualified sequence can be distributed to the proper temporary OTU respectively when a sequence similarity degree between the qualified sequence and an OTU sequence reaches at least 97%. The present disclosure also provides a sequence-assisted microorganism separation method.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: June 28, 2022
    Assignee: Perfect (China) Co., Ltd.
    Inventors: Liping Zhao, Jing Wang, Menghui Zhang
  • Publication number: 20200377945
    Abstract: The present invention provides a method for assessing the presence or the risk of development of type 2 diabetes mellitus in a subject based on abundance data of several CAGs. Also provided is a method for evaluating efficacy of diet intervention or disease treatment in a subject having type 2 diabetes mellitus based on abundance data of these CAGs.
    Type: Application
    Filed: January 29, 2019
    Publication date: December 3, 2020
    Applicant: PERFECT (CHINA) CO., LTD
    Inventors: Liping ZHAO, Chenhong ZHANG, Guojun WU, Menghui ZHANG
  • Patent number: 10130080
    Abstract: The application provides, among others, methods for constructing animal obesity models, methods for screening microorganism or composition of microorganisms that may cause obesity, methods for screening therapeutic targets for treating metabolic disorders, and methods for screening or evaluating microorganisms, compounds, food, recipes, formulations, drugs, nutritional supplements, healthcare products, beverages and other items for preventing and treating metabolic diseases.
    Type: Grant
    Filed: August 1, 2013
    Date of Patent: November 20, 2018
    Assignees: SHANGHAI JIAO TONG UNIVERSITY, PERFECT (CHINA) CO., LTD.
    Inventors: Liping Zhao, Na Fei
  • Patent number: 10010573
    Abstract: The present invention relates to a functional engineered rice having alcoholism relief and liver protection functions for those drinking alcohol over an extended period of time or drinking alcohol excessively, and preparation method thereof. The engineered rice comprises six starting materials: coarse rice powder, isolated soy protein, kudzu root extract, corn oligopeptide, purple sweet potato powder, and hawthorn extract, and is prepared by: premixing the starting materials; employing a double screw extruder to conduct texturized processing and forming under high temperature and high pressure; and then drying, dedusting and packaging.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: July 3, 2018
    Assignees: China National Research Institute of Food and Fermentation Industries Co., Ltd., Perfect (China) Co., Ltd.
    Inventors: Shenglin Duan, Muyi Cai, Zhe Dong, Yanqiao Liu, Xue Wang, Shiwei Liu, Jie Liu, Ruilian Hu, Zian Li
  • Publication number: 20180177833
    Abstract: This invention relates to novel probiotic Bifidobacteria strains, particularly, a B. pseudocatenulatum strain, and its use as probiotic, and food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of obesity, diabetes (particularly Type 2 diabetes), and related conditions.
    Type: Application
    Filed: June 30, 2015
    Publication date: June 28, 2018
    Applicant: PERFECT (CHINA) CO., LTD.
    Inventors: Liping ZHAO, Chenhong ZHANG, Huan WU, Guojun WU